ALDH1L1 and cancer: This hypothesis is further supported by the finding that ALDH1L1 is reversibly downregulated in the S-phase of the cell cycle in NIH3T3 cells, though through a different mechanism (i.e., proteasomal degradation in NIH3T3 cells versus promoter methylation in cancer cells) [31].